Profounda
UEI: NR1ZD3ETM3N6
• CAGE: 7K0V7
Overview
Parent Awardee
Federal Capability Statement
Profounda is a product-oriented, privately backed pharmaceutical company that aims to develop high quality specialty niche pharmaceutical products in both the branded and generic pharmaceutical markets.
Keywords
Impavido, drug, tropical, disease, allergy, rhinase, moisturize, wound care, dental, antibiotic, antifungal, nasal, leishmaniasis, amoebic
SBA Special Equipment
Impavido (miltefosine)
Rhinase (Nasal moisturizers)
Website
Headquarters
Orlando, FL
United States
United States
Most Recent Award
March 12, 2025
Calculating
Federal contract recipient
PROFOUNDA INC
(UEI NR1ZD3ETM3N6, CAGE 7K0V7)
is headquartered in Orlando FL.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in March 2013 and
federally registered in
February 2016.
Federal Award Analysis
Profounda federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
PROFOUNDA INC
Division Name
PROFOUNDA, INC.
Division Number
N/A
UEI
NR1ZD3ETM3N6
CAGE Code
7K0V7
Primary NAICS
SBA Certifications
None
Self Certifications
Self-Certified Small Disadvantaged Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
March 1, 2013
Initial Registration
Feb. 5, 2016
Last Registration
July 4, 2024
Registration Activation
July 4, 2024
Registration Expiration
July 2, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Manufacturer of Goods
Manufacturer of Goods
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Disaster Registry
Nationwide
Reported NAICS
Reported PSC
Accepts Credit Cards
Yes